NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active Pharmaceutical Ingredients (API) ...

Natco Pharma Ltd. reported on Friday that its active pharmaceutical ingredient manufacturing facility in Mekaguda, Hyderabad, ...

Published annually the Active Pharmaceutical Ingredients (API) Directory contains corporate information, senior executives, contact details email addresses of those working in every segment of the ...

Read full market research report on Active Pharmaceutical Ingredients (API) Market with TOC - Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report By Type of Synthesis ...

However, patients can find it difficult to identify the API in their medication as drugs are more commonly marketed with brand names. Analyzing incoming APIs in a pharmaceutical laboratory is ...

Ananthanarayanan (Ananth) as CEO of its Teva Active Pharmaceutical Ingredients business (Teva api). Dr. Ananth will lead the API business starting November 27, 2023, and will be based out of Teva ...

Orchid Pharma Ltd., a vertically integrated pharmaceutical company spanning the entire pharmaceutical value chain from discovery to delivery, announced the successful completion of a surprise US Food ...

The Noramco Group Addresses Critical Supply Chain Challenges, Offering Comprehensive Active Pharmaceutical Ingredients (API) and Drug Product Solutions- -Learn More from Company Leadership at DCAT ...

The growing demand for sustainable, natural treatments will likely position the plant-based API market at the forefront of global healthcare. As pharmaceutical companies continue to explore the ...

API manufacturer Granules Pharma has announced a restructuring to simplify its organisational structure, resulting in its American unit Granules USA transferring assets to Granules Pharma Inc and ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...

New DelhiEmcure Pharmaceuticals on Wednesday said the US health regulator has issued two observations after inspecting its Pune-based active pharmaceutical ingredients (API) manufacturing facility.